Performance vs S&P 500

03
Tracked Q4 2025–Q2 2026 -34.0%
S&P 500 total return (same window) +8.7%
Excess return -42.6%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

04
Healthcare 100.0%

Full portfolio 1 positions

05
Type Streak 8Q trend
CAI Caris Life Sciences, Inc. - Common Stock $200,592,879 100.00% 11,256,615 $-125,835,397 Down ×2

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
CAI Trimmed -7.0M -$125.8M